Skip to content

Clinical trials

Central Nervous System Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20122
20132
20141
20151
20163
20171
20182
20191
20204
20213
20221
20234
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated7
Unknown status3
Active, not recruiting3
Recruiting2
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca2
Bial R&D Investments, S.A.2
IRCCS San Raffaele Roma2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Amzell1
Biogen1
Danilo Toni1
Eli Lilly and Company1
Emalex Biosciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases31
Brain Diseases21
Nervous System Diseases14
Neurodegenerative Diseases13
Movement Disorders10
Mental Disorders9
Parkinson Disease7
Parkinsonian Disorders7
Alzheimer Disease6
Dementia6

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.